Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-07
DOI
10.1038/s41598-017-05752-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melatonin, an inhibitory agent in breast cancer
- (2016) Elaheh Nooshinfar et al. Breast Cancer
- Urinary Melatonin Concentration and the Risk of Breast Cancer in Nurses' Health Study II
- (2015) S. B. Brown et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nocturnal light pollution and underexposure to daytime sunlight: Complementary mechanisms of circadian disruption and related diseases
- (2015) Michael H. Smolensky et al. CHRONOBIOLOGY INTERNATIONAL
- Travail de nuit, travail posté : facteur de risque du cancer du sein ?
- (2015) J.-C. Benabu et al. GYNECOLOGIE OBSTETRIQUE & FERTILITE
- First-Morning Urinary Melatonin and Breast Cancer Risk in the Guernsey Study
- (2014) X.-S. Wang et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Urinary Excretion of Melatonin and Association with Breast Cancer: Meta-Analysis and Review of the Literature
- (2014) Michelle Basler et al. Breast Care
- Urinary Levels of Melatonin and Risk of Postmenopausal Breast Cancer: Women's Health Initiative Observational Cohort
- (2014) S. R. Sturgeon et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer
- (2014) R. T. Dauchy et al. CANCER RESEARCH
- Light exposure at night, sleep duration, melatonin, and breast cancer
- (2014) Wan-Shui Yang et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Low 25-hydroxyvitamin D concentrations may explain the link between breast cancer risk and shift work
- (2014) William B. Grant INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts
- (2014) Suthat Chottanapund et al. TOXICOLOGY IN VITRO
- The association between different night shiftwork factors and breast cancer: a case–control study
- (2013) L Fritschi et al. BRITISH JOURNAL OF CANCER
- Guidelines for optimizing design and analysis of clinical studies of nutrient effects
- (2013) Robert P Heaney NUTRITION REVIEWS
- Association of sleep duration and breast cancer OncotypeDX recurrence score
- (2012) Cheryl L. Thompson et al. BREAST CANCER RESEARCH AND TREATMENT
- Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore
- (2012) Anna H. Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night
- (2011) David E. Blask et al. JOURNAL OF PINEAL RESEARCH
- Urinary 6-Sulphatoxymelatonin Levels and Risk of Breast Cancer in Premenopausal Women: The ORDET Cohort
- (2010) E. S. Schernhammer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort
- (2009) E. S. Schernhammer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
- (2009) Stephen G. Grant et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Molecular Mechanisms of Melatonin Anticancer Effects
- (2009) Steven M. Hill et al. INTEGRATIVE CANCER THERAPIES
- Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms
- (2008) Venkataramanujan Srinivasan et al. INTEGRATIVE CANCER THERAPIES
- Combination of melatonin and a peroxisome proliferator-activated receptor-γ agonist induces apoptosis in a breast cancer cell line
- (2008) Ahmet Korkmaz et al. JOURNAL OF PINEAL RESEARCH
- Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal Women
- (2008) E. S. Schernhammer et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started